[1] 黎 燕, 罗维肖. 非典型抗精神病药与糖尿病关系的研究[J]. 临床精神医学杂志, 2002, 12(5):299-300.
[2] 林 琳, 瞿发林. 抗精神病药所致高催乳素血症的防治进展[J]. 实用药物与临床, 2010, 13(4):290-292.
[3] 牟晓东, 张 志. 抗精神病药物治疗与血糖调节紊乱[J]. 国外医学精神病学分册, 2004, 31(2):86-88.
[4] 娄素琴, 杨广声, 钱东丽. 抗精神病药物引起血糖升高135例[J]. 医药导报, 2006, 25(10):1009.
[5] Holt RI, Peveler RC. Association between antipsychotic drugs and diabetes[J]. Diabetes Obes Metab, 2006, 8(2):125-135.
[6] Allison DB, Casey DE. Antipsychotic-induced weight gain: a review of the literature[J]. J Clin Psychiatr, 2001, 62 (Suppl 7): 22-31.
[7] Lu CH, Yan YH. Risperidone-associated newly diagnosed diabetes and fatal diabetes ketoacidosis in a young schizophrenic patient[J]. Diabetes Res Clin Pract, 2009, 83(2):e66-67.
[8] Bostwick JR, Guthrie SK, Ellingrod VL. Antipsychotic-induced hyperprolactinemia[J]. Pharmacotherapy, 2009, 29(1) :64-73.
[9] Kapur S, Langlois X, Vinken P, et al. The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: a pharmacological analysis in rats[J]. J Pharmacol Exp Ther, 2002, 302(3):1129-1134.
[10] Staller J. The effect of long-term antipsychotic treatment on prolactin[J]. J Child Adolesc Psychopharmacol, 2006, 16(3):317-326.
[11] Knegtering R, Baselmans P, Castelein S, et al. Predominant role of the 9-Hydroxy metabolite of risperidone in elevating blood prolactin levels[J]. Am J Psychiatr, 2005, 162(5):1010-1012.
[12] Melkersson KI. Prolactin elevation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite[J]. Hum Psychopharmacol, 2006, 21(8): 529-532.
[13] Citrome L. Paliperidone: quo vadis?[J]. Int J Clin Pract, 2007, 61(4):653-662.
[14] Meltzer HY, Bobo WV, Nuamah IF, et al. Efficacy and tolerability of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 6-week, placebo-controlled studies[J]. J Clin Psychiatr, 2008, 69(5): 817-829.
[15] Einarson TR,Hemels ME,Nuamah I,et al.An analysis of potentially prolactin-related adverse events and abnormal prolactin values in randomized clinical trials with paliperidone palmitate[J].Ann Pharmacother,2012,46(10):1322-1330.
[16] Molitch ME. Drugs and prolactin[J]. Pituitary, 2008, 11(2): 209-218.
[17] Bankowski BJ, Zacur HA. Dopamine agonist therapy for hyperprolactinemia[J]. Clin Obstet Gynecol, 2003, 46 (2):349-362.
[18] 郭金宏,曹长安. 溴隐亭治疗抗精神病药物致高泌乳素血症的临床研究[J]. 神经疾病与精神卫生, 2003, 3(3) : 244.
[19] Lee MS, Song HC, An H, et al. Effect of bromocriptine on antipsychotic drug-induced hyperprolactinemia: eight-week randomized, single-blind, placebo-controlled, multicenter study[J]. Psychiatr Clin Neurosci, 2010, 64(1):19-27.
[20] Rocha FL, Hara C, Ramos MG. Using aripiprazole to attenuate paliperidone-induced hyperprolactinemia[J]. Prog Neuropsychopharmacol Biol Psychiatr, 2010, 34(6):1153-1154.
[21] 魏桂林, 徐小薇, 李大魁. 药物与高催乳素血症[J]. 药物不良反应杂志, 2000, 2(2):73-75.